Darmiyan
About Darmiyan
Darmiyan is a pioneering healthcare AI company focused on revolutionizing brain health management through advanced imaging technology. Their core mission is to provide early detection, visualization, and quantification of neurodegenerative disorders, with a primary focus on Alzheimer’s disease.
Their flagship product, BrainSee, is an FDA-approved, AI-powered clinical test designed for physicians. It utilizes advanced AI algorithms to analyze routine clinical brain MRIs and cognitive test results, generating a numerical score that predicts the likelihood of progression from amnestic mild cognitive impairment (aMCI) to Alzheimer’s dementia within five years. This non-invasive tool aims to empower healthcare providers with precise, personalized patient care by enabling timely interventions, guiding preventive strategies, and potentially delaying the onset of dementia, thereby improving patient outcomes. The technology is built upon over four decades of cutting-edge neuroscience research combined with sophisticated medical image processing and machine learning techniques.
What Physicians Need to Know
For physicians, Darmiyan's BrainSee offers actionable insights by providing an objective, patient-specific score (0-100%) that indicates the 5-year risk of progression to Alzheimer's dementia. This enables timely and personalized interventions, potentially delaying dementia onset and improving patient outcomes. The non-invasive nature and use of standard MRI scans mean it can be easily integrated into routine clinical workflows, and any licensed physician, including primary care providers, can prescribe the test. It helps in reassuring lower-risk patients, reducing the need for costly and invasive tests, and can be used to monitor the effectiveness of treatments and lifestyle modifications over time. Furthermore, BrainSee aids in selecting optimal candidates for clinical trials, advancing drug development for Alzheimer's.
Darmiyan's BrainSee platform is designed for seamless integration into existing clinical workflows. It combines standard clinical brain MRI data with cognitive assessments and is accessible to physicians via a secure and HIPAA-compliant web portal.
What the Web Says
Darmiyan is a company focused on brain health innovation, particularly in detecting neurodegenerative diseases like Alzheimer's at early stages. Their flagship product, BrainSee, is an AI-powered software that uses MRI brain scans and cognitive assessments to predict the likelihood of progression from mild cognitive impairment (MCI) to Alzheimer's dementia within five years. The company has received FDA De Novo approval for BrainSee, highlighting its potential as a non-invasive and accurate prognostic tool. Employer reviews are limited but generally positive, citing a supportive environment and passionate team.
Overall: PositiveStrengths
- BrainSee offers prognostic accuracy for Alzheimer's disease.
- BrainSee is a non-invasive diagnostic tool.
- BrainSee provides same-day test results.
- BrainSee integrates seamlessly into clinical workflows.
- Supportive management and flexible schedule reported by employees.
- Small, tight-knit, and passionate team environment.
Limitations
- Limited public employee reviews available.
- No specific product cons found in the provided search results.
- No specific company/employer cons found in the provided search results beyond the limited number of reviews.
- No reviews from G2, Glassdoor, Capterra, or Reddit were found for Darmiyan, only for similarly named companies or general review platforms.
Based on reviews from: Indeed.com, Darmiyan Website, Notebookcheck, MedTech Dive, BioSpace, Global Data
Last updated: 2026-07-18
Videos
News, demos, and interviews about Darmiyan.
Videos load interactively. If none appear, search YouTube for Darmiyan →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]